3Corenflo M,Bettendorf M,Ulmer HE,et al.Oxygen mediated pulmonary vasodilation and plasma levels of endothe linl,atrial natriuretic peptides and cyclic GMP in patients with lefttoright shunt and pulmonary hypertension.Z Kardiol,2000,89:100-108.
4Losonczy G,Kriston T,Szabo A.Male gender predisposes to development of endotoxic shock in the rat.Cardiouasc Res,2000,47(1):183-191.
5Steis BC,Levin RI.Natriuretic peptides:physiology,therapeuic potential and risk stratification in ischemic heart disease.Am Heart J,1998:914-923.
6Brockhoff C,Warnhol TZA,Munzel T.Atrial natriuratic peptides:diagnostic and therapeutic potential.Ther Umsch,2000,57:305-312.
7Honing MH,Smits P,Morrison PJ,et al.C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarixation in human resistance vessels.Hypertension,2001,37:1179-1183.
10Melol G,Steinhelper ME,Pang SC,et al.ANP in regulation of arterial pressure and fluid-electolyte balance:lessons from genetic mouse models[J].Physiol Genomic,2003,3(1):45-58.
